Is It Too Late to Get In On This Millionaire-Making Stock?

Is It Too Late to Get In On This Millionaire-Making Stock?
Taylor Carmichael, The Motley Fool
·4 min read

This is an amazing biotech with multiple drugs in pivotal trials. The U.S. Food and Drug Administration (FDA) has named this drug a breakthrough therapy in two indications: major depressive disorder and agitation caused by Alzheimer's Disease. Axsome is prepping its new drug application (NDA) right now for AXS-05 to treat major depressive disorder.